Peripheral arterial stiffness and endothelial dysfunction in idiopathic and scleroderma associated pulmonary arterial hypertension

Journal of Rheumatology

Volumn 36, Issue 5, 2009, Pages 970-975

  Peled, Nir ^a   Shitrit, David ^a   Fox, Benjamin D ^a   Shlomi, Dekel ^a   Amital, Anat ^a   Bendayan, Daniele ^a   Kramer, Mordechai R ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

Arterial stiffness; Augmentation index; Endothelial dysfunction; Pulmonary arterial hypertension; Scleroderma

Indexed keywords

NITRIC OXIDE;

ADULT; ARTERIAL STIFFNESS; ARTERY DILATATION; ARTERY OCCLUSION; ARTERY TONE; ARTICLE; AUGMENTATION INDEX; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; FEMALE; FOREARM BLOOD FLOW; HUMAN; IDIOPATHIC DISEASE; LUNG PRESSURE; MALE; PLETHYSMOGRAPH; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULSE PRESSURE; SCLERODERMA; SYSTOLIC BLOOD PRESSURE; TONOMETRY; VASODILATATION; BLOOD PRESSURE; CROSS-SECTIONAL STUDY; ELASTICITY; MIDDLE AGED; MUSCLE TONE; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASE; PHYSIOLOGY; PROSPECTIVE STUDY; PULMONARY ARTERY; SYSTEMIC SCLEROSIS; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE;

BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; ELASTICITY; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; MUSCLE TONUS; PERIPHERAL VASCULAR DISEASES; PROSPECTIVE STUDIES; PULMONARY ARTERY; SCLERODERMA, SYSTEMIC; VASCULAR RESISTANCE;

EID: 67449095291     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.081088     Document Type: Article

References (47)

1. Rubin LW. Pulmonary hypertension. Proc Am Thorac Soc 2006;3:111-5.
2. Humbert M, Stibon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004;351:1425-36.
3. Runo JR, Loyd JE. Primary pulmonary hypertension. Lancet 2003;361:1533-44.
4. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 1995;333:214-21.
5. Christman BW, McPherson CD, Newman JH, et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 1992;327:70-5.
6. Humbert M, Morrell N, Archer S, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43:S13-24.
7. Budhiraja R, Tuder RM, Hassoun PM. Endothelial dysfunction in pulmonary hypertension. Circulation 2004;109:159-65.
8. Laskey WK, Ferrari VA, Palevsky HI, Kussmaul WG. Pulmonary artery hemodynamics in primary pulmonary hypertension. J Am Coll Cardiol 1993;21:406-12.
9. Castelain V, Hervé P, Lecarpentier Y, Duroux P, Simonneau G, Chemla D. Pulmonary artery pulse pressure and wave reflection in chronic pulmonary thromboembolism and primary pulmonary hypertension. J Am Coll Cardiol 2001;37:1085-92.
10. Munir S, Guilcher A, Kamalesh T, et al. Peripheral augmentation index defines the relationship between central and peripheral pulse pressure. Hypertension 2008;51:112-8.
11. Izzo JL Jr, Shykoff BE. Arterial stiffness: clinical relevance, measurement, and treatment. Rev Cardiovasc Med 2001;2:29-40.
12. Haller MJ, Silverstein JH, Shuster JJ. Correlation between radial artery tonometry- and fingertip tonometry-derived augmentation index in children with type 1 diabetes. Diab Vasc Dis Res 2007;4:66.
13. Izzo JL Jr. Hypertension in the elderly: a pathophysiologic approach to therapy. J Am Geriatr Soc 1982;30:352-9.
14. Cheng KS, Baker CR, Hamilton G, Hoeks AP, Seifalian AM. Arterial elastic properties and cardiovascular risk/event. Eur J Vasc Endovasc Surg 2002;24:383-97.
15. McVeigh GE, Bratteli CW, Morgan DJ, et al. Age related abnormalities in arterial compliance identified by pressure pulse contour analysis. Aging and arterial compliance. Hypertension 1999;33:1392-8.
16. Bonetti PO, Pumper GM, Higano ST, Holmes DR, Kuvin JT, Lerman A. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol 2004;44:2137-41.
17. Kuvin JT, Patel AR, Sliney KA, et al. Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J 2003;146:168-74.
18. Bonetti PO, Barsness GW, Keelen PC, et al. Enhanced external counterpulsation improved endothelial function in patients with symptomatic coronary artery disease. J Am Coll Cardiol 2003;41:176-8.
19. Kuvin J, Patel A, Karas R. Need for standardization of non-invasive assessment of vascular endothelial function. Am Heart J 2001;144:327-8.
20. Kuvin J, Patel A, Sliney K, et al. Peripheral vascular endothelial function testing as a non-invasive indicator of coronary artery disease. Am J Coll Cardiol 2001;38:1843-9.
21. Schroeter H, Heiss C, Balzer J, et al. Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Nat Acad Sci USA 2006;103:1024-9.
22. Meredith IT, Currie KE, Anderson TJ, Roddy MA, Ganz P, Vreager MA. Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide. Am J Physiol 1996;270:H1435-40.
23. Peled N, Bendayan D, Shitrit D, Fox B, Yehoshua L, Kramer MR. Peripheral endothelial dysfunction in patients with pulmonary hypertension. Respir Med 2008;102:1631-5.
24. Itzhaki S, Dorchin H, Clark G, Lavie L, Lavie P, Pillar G. The effects of 1-year treatment with a herbst mandibular advancement splint on obstructive sleep apnea, oxidative stress, and endothelial function. Chest 2007;131:740-9.
25. Yinon D, Lowenstein L, Suraya S, et al. Pre-eclampsia is associated with sleep-disordered breathing and endothelial dysfunction. Eur Respir J 2006;27:328-33.
26. Itzhaki S, Lavie L, Pillar G, Tal G, Lavie P. Endothelial dysfunction in obstructive sleep apnea measured by peripheral arterial tone response in the finger to reactive hyperemia. Sleep 2005;28:594-600.
27. Haller MJ, Samyn M, Nichols WW, et al. Radial artery tonometry demonstrates arterial stiffness in children with type 1 diabetes. Diabetes Care 2004;27:2911-7.
28. Haller MJ, Stein J, Shuster J, et al. Peripheral artery tonometry demonstrates altered endothelial function in children with type 1 diabetes. Pediatr Diabetes 2007;8:193-8.
29. Oliver JJ, Webb DJ. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol 2003;23:554-66.
30. Wilkinson IB, Qasem A, McEniery CM, Avolio AP, Cockcroft JR. Nitric oxide regulates local arterial distensibility in vivo. Circulation 2002;105:213-7.
31. Bank AJ, Kalser DR, Rajala S, Cheng A. In vivo human brachial artery elastic mechanics: effects of smooth muscle relaxation. Circulation 1999;100:41-7.
32. Medley TL, Cole TJ, Gatzka CD, Wang WY, Dart AM, Kingwell BA. Fibrillin-1 genotype is associated with aortic stiffness and disease severity in patients with coronary artery disease. Circulation 2002;105:810-5.
33. Lajemi M, Labat C, Gautier S, et al. Angiotensin II type 1 receptor-153A/G and 1166A/C gene polymorphisms and increase in aortic stiffness with age in hypertensive subjects. J Hypertens 2001;19:407-13.
34. Ha B, Lucas CL, Henry WH, Frantz EG, Ferreiro JI, Wilcox BR. Effects of chronically elevated pulmonary arterial pressure and flow on right ventricular afterload. Am J Physiol 1994;267:H155-65.
35. Yin FCP, Ting CT. Wave reflection in pulmonary hypertension. In: Wier EK, Archer SL, Reeves JT, editors. The diagnosis and treatment of pulmonary hypertension. Mount Kisco, NY: Futura; 1992:111-23.
36. Kussmaul WG, Noordergraaf A, Laskey WK. Right ventricular pulmonary interactions. Ann Biomed Eng 1992;20:63-80.
37. Karamanoglu M, McGoon M, Frantz RP, et al. Right ventricular pressure waveform and wave reflection analysis in patients with pulmonary arterial hypertension. Chest 2007;132:37-43.
38. Constans J, Germain C, Gosse P, et al. Arterial stiffness predicts severe progression in systemic sclerosis: the ERAMS study. J Hypertens 2007;25:1900-6.
39. Moyssakis I, Gialafos E, Vassiliou V, et al. Aortic stiffness in systemic sclerosis is increased independently of the extent of skin involvement. Rheumatology 2005;44:251-4.
40. Andersen GN, Mincheva-Nilsson L, Kazzam E, et al. Assessment of vascular function in systemic sclerosis: indications of the development of nitrate tolerance as a result of enhanced endothelial nitric oxide production. Arthritis Rheum 2002;46:1324-32.
41. Hughes R, Tong J, Oats C, Lordan J, Corris PA. Evidence for systemic endothelial dysfunction in patients and first-order relatives with pulmonary hypertension. Chest 2005;128:617S.
42. Bull TM, Golpon H, Hebbel RP, et al. Circulating endothelial cells in pulmonary hypertension. Thromb Haemost 2003;90:698-703.
43. Dorfmuller P, Perros F, Balabanian K, Humbert M. Inflammation in pulmonary arterial hypertension. Eur Respir J 2003;22:358-63.
44. Eddahibi S, Humbert M, Fadel E, et al. Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest 2001;108:1141-50.
45. Friedman R, Mears JG, Barst RJ. Continuous infusion of prostacyclin normalizes plasma markers of endothelial cell injury and platelet aggregation in primary pulmonary hypertension. Circulation 1997;96:2782-4.
46. Eisenberg PR, Lucore C, Kaufman L, Sobel BE, Jaffe AS, Rich S. Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension. Circulation 1990;82:841-7.
47. Velez-Roa S, Ciarka A, Najem B, Vachiery JL, Naeije R, Van de Borne P. Increased sympathetic nerve activity in pulmonary hypertension. Circulation 2004;110:1308-12.